Depression and health-related quality of life in critical COVID-19 survivors

• Type: Other Publications
• Date: 2022

Authors

Silva, J (Author) Other; Martins, S (Author) Other; Ferreira, AR (Author) FMUP; Fernandes, J (Author) Other; Vieira, T (Author) Other; Fontes, L (Author) Other; Reis, N (Author) Other; Braga, A (Author) Other; Coimbra, I (Author) Other; Paiva, J-A (Author) FMUP; Lia Fernandes (Author) FMUP

Other information

Authenticus ID: P-00X-6BH

DOI: 10.1192/j.eurpsy.2022.956

Abstract (EN): <jats:sec id="S0924933822009567_sec06061" sec-type="intro"> <jats:title>Introduction</jats:title> <jats:p>Long-term neuropsychiatric consequences of critical illness are well known. Therefore, it is expected that critical COVID-19 patients might also present several psychiatric symptoms such as depression, with inevitable negative effect on health-related quality of life (HRQoL), commonly used as an indicator of illness and treatment impact.</jats:p> </jats:sec> <jats:sec id="S0924933822009567_sec06062"> <jats:title>Objectives</jats:title> <jats:p>To identify depressive symptoms in critical COVID-19 survivors and to examine its association with HRQoL domains.</jats:p> </jats:sec> <jats:sec id="S0924933822009567_sec06063" sec-type="methods"> <jats:title>Methods</jats:title> <jats:p>This preliminary study involved critical COVID-19 patients admitted into the Intensive Care Medicine Department (ICMD) of a University Hospital, between October and December of 2020. Patients with an ICMD length of stay (LoS)¿24h, terminal illness, major auditory loss, or inability to communicate at the follow-up time were excluded. From 1-2 months after discharge, all participants were evaluated by telephone at follow-up appointment, with Patient Health Questionnaire (PHQ-9) (depression) and EuroQol 5-dimension 5-level EQ-5D-5L (HRQoL). This study is part of the longitudinal MAPA project.</jats:p> </jats:sec> <jats:sec id="S0924933822009567_sec06064" sec-type="results"> <jats:title>Results</jats:title> <jats:p>Eighty-three patients were included with a median age of 63 years (range: 31-86) and the majority were male (63%). The most reported problems on EQ-5D-5L domains were usual activities (82%) and mobility (76%). About 27% presented depressive symptoms, and with more problems of self-care (68%vs41%; p=0.029), pain/discomfort (86%vs49%; p=0.002), and anxiety/depression (96%vs54%; p<0.001).</jats:p> </jats:sec> <jats:sec id="S0924933822009567_sec06065" sec-type="conclusions"> <jats:title>Conclusions</jats:title> <jats:p>These preliminary results are in line in previous studies in critical COVID-19 survivors, with depression being associated with worse HRQoL. Bearing this in mind, follow-up approaches with an early screening and treatment of these psychiatric symptoms will be fundamental to optimize the recovery of these patients.</jats:p> </jats:sec> <jats:sec id="S0924933822009567_sec06066"> <jats:title>Disclosure</jats:title> <jats:p>No significant relationships.</jats:p> </jats:sec>

Language: English

Type (Professor's evaluation): Scientific